Peter Heydemann to Walk Test
This is a "connection" page, showing publications Peter Heydemann has written about Walk Test.
Connection Strength
0.050
-
A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment. J Neuromuscul Dis. 2022; 9(1):39-52.
Score: 0.050